Based on 1 analyst offering 12 month price targets for Biosig Technologies Inc
Min Forecast
$2.75+404.59%
Avg Forecast
$2.75+404.59%
Max Forecast
$2.75+404.59%
Should I buy or sell BSGM stock?
Based on 1 analyst offering ratings for Biosig Technologies Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BSGM's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BSGM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their BSGM stock forecasts and price targets.
BSGM stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2024-12-05
1 of 1
Forecast return on equity
Is BSGM forecast to generate an efficient return?
Insufficient data to display
Forecast return on assets
Is BSGM forecast to generate an efficient return on assets?
Company
N/A
Industry
12.4%
BSGM earnings per share forecast
What is BSGM's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.73
BSGM revenue forecast
What is BSGM's revenue in the next 1 years based on estimates from 1 analyst?
Is Biosig Technologies Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BSGM) stock is to Buy BSGM stock.
Out of 1 analyst, 0 (0%) are recommending BSGM as a Strong Buy, 1 (100%) are recommending BSGM as a Buy, 0 (0%) are recommending BSGM as a Hold, 0 (0%) are recommending BSGM as a Sell, and 0 (0%) are recommending BSGM as a Strong Sell.
What is BSGM's earnings growth forecast for 2025-2025?
(NASDAQ: BSGM) Biosig Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 25.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 24.08%.
Biosig Technologies's earnings in 2025 is -$15,446,000.
In 2025, BSGM is forecast to generate -$12,581,498 in earnings, with the lowest earnings forecast at -$12,581,498 and the highest earnings forecast at -$12,581,498.
What is BSGM's revenue growth forecast for 2025-2025?
(NASDAQ: BSGM) Biosig Technologies's forecast annual revenue growth rate of 279.27% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.02%.
Biosig Technologies's revenue in 2025 is $39,000.
In 2025, BSGM is forecast to generate $5,170,479 in revenue, with the lowest revenue forecast at $5,170,479 and the highest revenue forecast at $5,170,479.
What is BSGM's forecast return on assets (ROA) for 2025-2027?
(NASDAQ: BSGM) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 12.4%.
What is BSGM's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BSGM price target, the average BSGM price target is $2.75, with the highest BSGM stock price forecast at $2.75 and the lowest BSGM stock price forecast at $2.75.
The Wall Street analyst predicted that Biosig Technologies's share price could reach $2.75 by Dec 5, 2025. The average Biosig Technologies stock price prediction forecasts a potential upside of 404.59% from the current BSGM share price of $0.55.
What is BSGM's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: BSGM) Biosig Technologies's current Earnings Per Share (EPS) is -$1.43. In 2025, BSGM's EPS is forecast to hit -$0.73 (min: -$0.73, max: -$0.73).
What is BSGM's forecast return on equity (ROE) for 2025-2027?
(NASDAQ: BSGM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.